World's Best Scientists 2026 revealed!
Mark Hyman Rapaport

Mark Hyman Rapaport

D-Index & Metrics

Medicine

D-Index
76
Citations
28004
World Ranking
18651
National Ranking
9290

Mark Hyman Rapaport publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark Hyman Rapaport sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 294 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark Hyman Rapaport D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark Hyman Rapaport sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 76 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mark Hyman Rapaport is affiliated with Emory University in the United States. Their research intersects multiple fields including Neuroscience, Medicine, and Biochemistry, Genetics and Molecular Biology, with significant contributions in Genetics, Biological Psychiatry, and Psychiatry and Mental Health as subfields.

The scientist's main research focuses encompass a variety of topics related to brain and mental health, including:

  • Tryptophan and brain disorders
  • Stress Responses and Cortisol
  • Genetic Associations and Epidemiology
  • Psychosomatic Disorders and Their Treatments
  • Genomics and Rare Diseases
  • Vagus Nerve Stimulation Research
  • Heart Rate Variability and Autonomic Control

Mark Hyman Rapaport has contributed to several recent papers that have appeared in a range of scientific journals. These include:

  • "Rare coding variants in ten genes confer substantial risk for schizophrenia," published in 2022 in Nature
  • "Diet, Stress and Mental Health," published in 2020 in Nutrients
  • "Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits," published in 2020 in Frontiers in Psychiatry
  • "Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans," published in 2020 in Schizophrenia Bulletin
  • "Application of Noninvasive Vagal Nerve Stimulation to Stress-Related Psychiatric Disorders," published in 2020 in Journal of Personalized Medicine

The frequent co-authors collaborating with Rapaport include:

  • Becky Kinkead
  • Boadie W. Dunlop
  • Pamela J. Schettler
  • P.F. Buckley
  • Dolores Malaspina

Rapaport's work is often published in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Clinical Psychiatry
  • CNS Spectrums
  • Brain Behavior & Immunity - Health
  • Nature

Best Publications

  • Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

    Herbert Y. Meltzer;Larry Alphs;Alan I. Green;A. Carlo Altamura

  • Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology

    Niamh Mullins;Andreas J. Forstner;Andreas J. Forstner;Andreas J. Forstner;Kevin S. O'Connell;Kevin S. O'Connell;Brandon Coombes

  • A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

    D R Goldsmith;M H Rapaport;B J Miller

  • Quality-of-life impairment in depressive and anxiety disorders.

    Mark Hyman Rapaport;Cathryn Clary;Rana Fayyad;Jean Endicott

  • Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

    A. John Rush;Lauren B. Marangell;Harold A. Sackeim;Mark S. George;Mark S. George

  • Socioeconomic Burden of Subsyndromal Depressive Symptoms and Major Depression in a Sample of the General Population

    Lewis L. Judd;Martin P. Paulus;Kenneth B. Wells;Mark H. Rapaport

  • Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration.

    Barbara L Brody;Anthony C Gamst;Rebecca A Williams;Amanda R Smith

  • Subsyndromal symptomatic depression: a new mood disorder?

    Lewis L. Judd;Mark Hyman Rapaport;Martin P. Paulus;John L. Brown

  • TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament.

    Hagop S. Akiskal;Hagop S. Akiskal;Mauro V. Mendlowicz;Mauro V. Mendlowicz;Girardin Jean-Louis;Mark H. Rapaport;Mark H. Rapaport

  • Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine.

    David Pickar;Richard R. Owen;Robert E. Litman;P. Eric Konicki

  • A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22

    John R. Kelsoe;M. Anne Spence;Erika Loetscher;Montserrat Foguet

  • Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study

    Mark Hyman Rapaport;Andrew A Nierenberg;Pamela J. Schettler;Becky Kinkead

  • Quality of life: the ultimate outcome measure of interventions in major depressive disorder.

    Waguih William IsHak;Jared Matt Greenberg;Konstantin Balayan;Nina Kapitanski

  • C-reactive protein levels in schizophrenia: a review and meta-analysis.

    Brian J. Miller;Nick Culpepper;Mark H. Rapaport

  • Clinical and Physiological Consequences of Rapid Tryptophan Depletion

    Polly Moore;Polly Moore;Hans-Peter Landolt;Erich Seifritz;Erich Seifritz;Camellia Clark

  • Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment

    Mark Hyman Rapaport;Lewis L Judd

  • Diet, Stress and Mental Health.

    J Douglas Bremner;J Douglas Bremner;Kasra Moazzami;Matthew T Wittbrodt;Jonathon A Nye

  • A descriptive analysis of minor depression.

    Mark Hyman Rapaport;Lewis L. Judd;Pamela J. Schettler;Kimberly Ann Yonkers

  • Elevated levels of soluble interleukin 2 receptors in schizophrenia.

    Mark Hyman Rapaport;Cathy G. McAllister;David Pickar;David L. Nelson

  • Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder.

    Lev Gertsik;Russell E. Poland;Catherine Bresee;Mark Hyman Rapaport

Frequent Co-Authors

John R. Kelsoe
John R. Kelsoe University of California, San Diego
J. Christian Gillin
J. Christian Gillin University of California, San Diego
Peter F. Buckley
Peter F. Buckley University of Tennessee Health Science Center
David Mischoulon
David Mischoulon Harvard University
Steven A. McCarroll
Steven A. McCarroll Harvard University
Andrew A. Nierenberg
Andrew A. Nierenberg Harvard University
Boadie W. Dunlop
Boadie W. Dunlop Emory University
Mauro V. Mendlowicz
Mauro V. Mendlowicz Federal University of Rio de Janeiro
Dolores Malaspina
Dolores Malaspina Icahn School of Medicine at Mount Sinai
David Pickar
David Pickar National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA can lead to diverse and rewarding career options beyond the traditional MD. Many healthcare professionals are choosing alternative routes, such as administration, nursing, or pharmacy, made even more accessible through online education.

For those interested in leadership roles, cheapest online mha programs offer a pathway to overseeing hospital operations and improving healthcare systems. Nurses seeking top credentials may consider the best online bsn to dnp programs, which provide advanced practice and research skills.

If pharmacy interests you, a 3-year online pharmd can quickly prepare students for clinical or consulting roles. Meanwhile, those inclined toward health data and technology can achieve management positions through rhia certification programs online.

These online degrees offer flexibility and affordability for students aiming to advance or pivot in the healthcare field, helping them meet the evolving demands of modern medicine.

Best Scientists Citing Mark Hyman Rapaport

Trending Scientists

Recently Published Articles